北美肠内喂养配方奶粉市场 – 行业趋势及 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

北美肠内喂养配方奶粉市场 – 行业趋势及 2030 年预测

  • Healthcare
  • Upcoming Report
  • Jan 2023
  • North America
  • 350 页面
  • 桌子數: 220
  • 图号: 60

North America Enteral Feeding Formula Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 1,539.58 Million
Diagram Market Size (Forecast Year)
USD 2,625.58 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Nutricia
  • Hormel Foods Corporation
  • Medline Industries
  • Mead Johnson & Company LLC.
  • Nestlé Health Science

>北美肠内喂养配方市场,按产品(标准配方、糖尿病配方、肾配方、肝配方、肺配方、肽基配方、其他疾病特定配方和疾病特定配方)、应用(肿瘤学、神经病学、重症监护、糖尿病、胃肠病学等)、管饲类型(胃管喂养、鼻胃管喂养、胃造口管喂养和十二指肠或空肠管喂养)、阶段(成人和儿科)、最终用户(医院、疗养院、辅助生活设施、家庭护理机构、临终关怀和长期护理机构)划分——行业趋势和预测到 2030 年。

北美肠内喂养配方市场

北美肠内喂养配方市场分析及规模

根据世界卫生组织的数据,中低收入国家占癌症死亡人数的近 70%。由于慢性疾病和病症的增加、人口快速老龄化、早产率的上升、医疗成本的上升以及家庭护理需求的增加,肠内营养配方行业正在不断扩大。因此,肠内营养使用鼻胃管或经皮胃管和肠管绕过消化系统。这些喂养技术能够满足老年患者的需求。尽管如此,吞咽系统的康复和为老年患者提供最佳功能是主要目标。

Data Bridge Market Research 分析,肠内喂养配方市场在 2022 年的规模为 15.3958 亿美元,预计到 2030 年将达到 26.2558 亿美元,在 2023 年至 2030 年的预测期内,复合年增长率为 6.9%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

北美肠内喂养配方市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

产品(标准配方、糖尿病配方、肾脏配方、肝脏配方、肺部配方、肽基配方、其他疾病特定配方和疾病特定配方)、应用(肿瘤科、神经科、重症监护、糖尿病、胃肠病学和其他)管饲类型(胃管饲、鼻胃管饲、胃造口管饲和十二指肠或空肠管饲)、阶段(成人和儿童)、最终用户(医院、疗养院、辅助生活设施、家庭护理机构、临终关怀和长期护理机构)

覆盖国家

北美的美国、加拿大和墨西哥

涵盖的市场参与者

Nutricia (Netherlands), Hormel Foods Corporation (U.S.), Medline Industries, Inc. (U.S.), Mead Johnson & Company, LLC. (U.S.), Nestlé Health Science (Switzerland), Abbott (U.S.), Meiji Holdings Co., Ltd. (Japan), Fresenius Kabi AG (Germany), B. Braun SE (Germany), Trovita Health Science (U.S.), Victus Inc. (U.S.), Avanos Medical Inc. (U.S.), Cardinal Health (U.S.), Moog Inc (U.S.), Conmed Corporation (U.S.), Cook Medical (India)

Market Opportunities

  • New product launches in the enteral feeding market
  • Growing elderly population

Market Definition

Enteral tube feeding introduces nutrients into the stomach or intestines via tubes for those who are unable to meet their nutritional needs or absorb nutrients orally. For enteral feed formula, tubes such as nasojejunal tubes, nasogastric tubes, gastrostomy tubes, and jejunostomy tubes are available. The various methods for delivering nutrients are inexpensive, nutritious and a viable alternative to invasive surgery.

North America Enteral Feeding Formula Market Dynamics

Drivers

  • The rise in the geriatric population

Chronic diseases are spreading across North America as a result of the continually expanding elderly population. The rising geriatric population (those 85 and older) in the EU-27 has numerous effects. As significantly senior persons require proportionally more social services, the cost of ensuring good health and long-term care is one of the key areas of worry for the relevant authorities. The senior population is the market's main target consumer since neurological conditions like multiple sclerosis, stroke, and dementia hinder swallowing.

  • Rise in the incidence of malnutrition

One of the major factors driving the adoption of enteral feeding formulas is an increase in the incidence of malnutrition, which is linked to higher ICU mortality. Malnutrition has a significant death rate in several regions of the world, despite being a common illness that is frequently ignored and underappreciated globally. For instance, malnutrition is thought to be the cause of roughly 45% of fatalities among children under the age of five, with mortality rates higher in low- and middle-income countries. This is the factor which drives the market growth.

Opportunities

  • New product launches in the enteral feeding market

A rise in product launches and product development by manufacturers is one of the major factors influencing the market. For instance, Victus, Inc. launched "Abintra Care," a specialised nutritional supplement, in 2020. It contains various essential minerals such as vitamin C, antioxidants, zinc and selenium. This simple-to-use rotating peristaltic pump makes enteral nutrition delivery easier. This device is both safe and accurate because it has sound and light alarm features to warn the user of a pipeline blockage or low battery voltage.

Restraints/Challenges

  • Complications associated with enteral feeding

According to the National Center for Biotechnology Information, gastrostomy and jejunostomy feeding tubes are frequently implanted and used for long-term home enteral nutrition support. Although the placement of these tubes is typically accompanied with modest morbidity, prolonged use can lead to a number of issues and diseases that can lower quality of life and have significant cost repercussions. The region's market for enteral feeding formula is slowly expanding due to all of these causes.

This enteral feeding formula market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the enteral feeding formula market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In October 2020, China's first ready-to-drink protein-based total nutrition Foods launched by Nestle Health Science for Special Medical Purposes (FSMPs) for malnourished people.
  • In June 2020, Enoras Liquid launched by Otuska Pharmaceuitical Factory Inc., an enteral polymeric enteric nutrition.

North America Enteral Feeding Formula Market Scope

The enteral feeding formula market is segmented on the basis of product, stage, type of tube feeding, indication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Standard formula
  • Disease-specific formula
  • Diabetic Formula
  •  Renal Formula
  • Hepatic Formula
  •  Pulmonary Formula
  •  Peptide-based Formula
  • Other Disease Specific Formula

Stage

  • Adult
  • Pediatric

Indication

  • Alzheimer's
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/G.I. Disorder/Diarrhea
  • Others

Type of Tube Feeding

  • Gastric Tube Feeding
  • Nasogastric Tube Feeding
  • Gastrostomy Tube Feeding
  • Duodenal or Jejunal Tube Feeding

End-user

  • Hospitals
  • Cardiology
  • Neurology
  • Critical Care (ICU)
  • Oncology
  • Others
  • Home Care
  • Nursing Homes
  • Assisted Living Facilities
  • Home Care Agencies
  • Hospices

Enteral Feeding Formula Market Regional Analysis/Insights

The enteral feeding formula market is analyzed and market size insights and trends are provided by country, product, stage, type of tube feeding, indication and end-user as referenced above.

The countries covered in the enteral feeding formula market report are U.S., Canada and Mexico in North America.

由于美国地区肠内喂养配方使用率高、早产率高、研发项目数量不断增加、以及该地区患病老年人肠内喂养配方采用率高,美国在市场上占据主导地位并引领北美市场的增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和肠内喂养配方市场份额分析

肠内喂养配方奶粉市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、北美业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对肠内喂养配方奶粉市场的关注有关。

肠内喂养配方奶粉市场的一些主要参与者包括:

  • Nutricia(荷兰)
  • 荷美尔食品公司(美国)
  • Medline Industries, Inc.(美国)
  • 美赞臣公司(Mead Johnson & Company, LLC.)(美国)
  • 雀巢健康科学(瑞士)
  • 雅培(美国)
  • 明治控股株式会社(日本)
  • 费森尤斯卡比公司(德国)
  • B. Braun SE(德国)
  • Trovita Health Science(美国)
  • Victus Inc.(美国)
  • Avanos Medical Inc.(美国)
  • 康德乐 (美国)
  • Moog Inc(美国)
  • Conmed Corporation(美国)
  • 库克医疗(印度)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on , By Product (Standard Formulas, Diabetic Formula, Renal Formula, Hepatic Formula, Pulmonary Formula, Peptide-based Formula, Other Disease Specific Formula, and Disease-Specific Formulas), Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology, and Others), Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrostomy Tube Feeding, and Duodenal or Jejunal Tube Feeding), Stage (Adult and Pediatric), End User (Hospitals, Nursing Homes, Assisted Living Facilities, Home Care Agencies, and Hospices and Long Term Care Facilities) – Industry Trends and Forecast to 2030. .
The North America Enteral Feeding Formula Market size was valued at USD 1539.58 USD Million in 2022.
The North America Enteral Feeding Formula Market is projected to grow at a CAGR of 6.9% during the forecast period of 2023 to 2030.
The major players operating in the market include Nutricia, Hormel Foods Corporation, Medline Industries , Mead Johnson & Company LLC., Nestlé Health Science, Abbott, Meiji Holdings Co. , Fresenius Kabi AG, B. Braun SE, Trovita Health Science, Victus , Avanos Medical , Cardinal Health, Moog , Conmed Corporation, Cook Medical,.
The market report covers data from the U.S., Canada and Mexico in North America.